Sodium Acetate Anhydrous Solution, Concentrate
Product Images NDC 70069-047

This text appears to be a detailed description of a pharmaceutical product containing sodium acetate, with instructions for intravenous use. It highlights the composition, pH level, proper handling procedures, and storage requirements. The text emphasizes the importance of dilution, aseptic technique, and the specific guidelines for preparing and administering the solution. It also mentions the manufacturer and contains cautionary notes for use.*

This text appears to be a medication label for Sodium Acetate Injection, USP. It provides important information such as the content of sodium acetate in each mL, storage instructions, dosage information, and usage guidelines for preparing intravenous admixtures. The medication is sterile and nonpyrogenic, intended for IV use only. It should be diluted properly before administration and the vial should be discarded after 4 hours of initial entry. The product is manufactured by Somerset Therapeutics, LLC in Somerset, NJ and there is a customer care number provided for inquiries. It is a Pharmacy Bulk Package not for direct infusion and is made in India.*

This text appears to be a product description for Sodium Acetate Injection, USP. It contains information regarding the concentration per mL, pharmacy bulk package, usage instructions, storage conditions, and manufacturer details. The product is indicated for intravenous use in preparing intravenous admixtures only. It is sterile, nonpyrogenic, and should be discarded 4 hours after initial entry. For complete dosage information and proper use, one should refer to the insert provided with the product. It is also noted that no more than 200 mcg/L of aluminum is present in the solution.*

This scan provides information about a pharmaceutical product called Sodium Acetate Injection, USP. Each mL contains 164 mg of sodium acetate, anhydrous, and may include glacial acetic acid for pH adjustment. The solution is sterile, nonpyrogenic, and should be used for preparing intravenous admixtures only. It is recommended to transfer individual doses to intravenous infusion solutions using a sterile dispensing set or transfer device, as the use of a syringe with a needle is not advised. The administration process should take place under a laminar flow hood with aseptic techniques. The product should be stored at 20 to 25°C (68 to 77°F). The item is produced by Somerset Therapeutics, LLC, located in Somerset, NJ, and includes customer care contact information. The labeling warns that the solution is for intravenous use only and must be diluted before use, and it is not intended for direct infusion.*